Latest news with #Centennial2071
Sharjah 24
21-05-2025
- Health
- Sharjah 24
FOCP, EHS partner to drive national cancer detection efforts
The agreement, signed by Dr Shamsa Majid Lootah, Director of the Public Health Department at EHS, and Aisha Al Mulla, Director of FOCP, underscores FOCP's ongoing commitment to working collaboratively with national healthcare institutions to benefit the wider community. It sets out a framework for expanding early detection programmes and strengthening both financial and emotional assistance for patients. EHS has long been a strategic partner of FOCP, with both organisations having previously joined forces on cancer awareness initiatives. The renewed partnership provides a platform to broaden the scope of collaboration and align efforts in support of the UAE's national strategy to curb cancer prevalence and lessen its impact on patients and their families. A strategic step towards shared goals Commenting on the partnership, Dr. Essam Al Zarouni, Acting Executive Director of the Medical Services Sector at EHS, affirmed that the MoU represents an advanced integration model among national sectors pursuing the country's healthcare goals. This collaboration aligns with the National Strategy for Wellbeing 2031 objectives and the UAE Centennial 2071. For her part, Dr. Shamsa Lootah highlighted that EHS is committed to expanding strategic partnerships with key community stakeholders to support its focus on disease prevention and early detection, particularly for cancer. Through ongoing awareness programmes and initiatives, EHS aims to raise public awareness, encourage healthy lifestyles and improve early diagnosis and treatment, in line with its commitment to comprehensive healthcare. Aisha Al Mulla, Director of FOCP, said: 'The new partnership with EHS represents a significant step forward in our shared mission to raise community awareness of cancer and strengthen patient support systems. It builds on a longstanding collaboration between us. It reflects our joint conviction that coordinated efforts between the non-profit and healthcare sectors are vital to advancing early detection, improving prevention, and alleviating the challenges faced by patients and their families throughout their treatment journey.' Patient support and assessment As part of the agreement, FOCP's Patient Affairs Department will assess each cancer case to determine eligibility for financial assistance, in line with the organisation's established policies and procedures. In parallel, it will provide moral support, acknowledging its essential role in enhancing treatment outcomes and overall patient well-being. Awareness campaigns and joint programmes FOCP and EHS will collaborate on early cancer detection initiatives through public awareness campaigns, joint research projects, and specialised workshops and conferences. These efforts are designed to expand access to cancer-related services within the community, supporting prevention, early detection, and effective treatment.
Arabian Post
20-05-2025
- Business
- Arabian Post
Mubadala Bio Emerges as Pillar of UAE's Healthcare Vision
Mubadala Investment Company has unveiled Mubadala Bio, a new life sciences entity designed to bolster the United Arab Emirates' pharmaceutical manufacturing capabilities and enhance healthcare resilience. The initiative aligns with the country's Centennial 2071 vision, aiming to position Abu Dhabi as a regional hub for biopharmaceutical innovation. Mubadala Bio's infrastructure encompasses ten facilities across Asia, Africa, and Europe, with six situated within the UAE. Collectively, these sites span 110,000 square metres and possess an annual production capacity exceeding 2.5 billion tablets and capsules, along with 120 million intravenous and injectable units. The company's extensive portfolio includes over 10,000 medical products, serving more than 100 countries worldwide. The company's focus extends across the entire continuum of care, from prevention and diagnostics to treatment and supportive therapies. This comprehensive approach aims to address pressing global health challenges and improve patient outcomes. Dr. Bakheet Al Katheeri, CEO of Mubadala's UAE Investments Platform, stated that the launch of Mubadala Bio represents a transformative step toward strengthening national drug security and fostering innovation in life sciences. He emphasized that this positions Mubadala at the forefront of the industry, enabling long-term economic growth and the development of a resilient life sciences ecosystem. Ismail Ali Abdulla, Executive Director of UAE Clusters at Mubadala, highlighted the company's commitment to supporting the UAE's ambition to become a global leader in the life sciences industry. By focusing on local manufacturing and enhancing distribution and logistics capabilities, Mubadala Bio aims to build a self-sustaining sector prepared for future challenges. Mubadala Bio plans to establish strategic partnerships with global life sciences firms and academic institutions to accelerate biopharmaceutical innovation and nurture world-class talent within the UAE. These collaborations are intended to drive advancements in healthcare and support the country's transition to a knowledge-based economy. See also UAE Airlines Resume Flights to Pakistan After Airspace Reopening The company's launch will be formally introduced at the upcoming Make it in the Emirates 2025 event, showcasing the UAE's success in building a competitive life sciences industry. This event serves as a national industrial showcase, reinforcing the country's position as a hub for innovation and local manufacturing. Mubadala Bio is designated as one of Mubadala's 'National Champions,' entities established to support strategic sectors aligned with the UAE's long-term development goals. Through its initiatives, the company aims to accelerate the UAE's economic diversification, particularly in healthcare and biotechnology.
Al Etihad
19-05-2025
- Business
- Al Etihad
Mubadala Bio launched to transform life sciences in UAE and beyond
19 May 2025 11:32 ABU DHABI (WAM)Mubadala Investment Company, an Abu Dhabi sovereign investor, Monday announced the launch of Mubadala Bio, a life sciences company committed to strengthening the life sciences sector in the UAE, and advancing better health outcomes for the UAE and the launch of Mubadala Bio represents a strategic step that reflects Mubadala's commitment - to healthcare resilience, drug security, and the expansion of access to essential, high-quality therapeutics and medical devices - in order to accelerate the UAE's economic diversification and build a knowledge-based Bio's integrated portfolio includes 10 facilities across Asia, Africa, and Europe alongside 6 located within the Emirates, which together serve over 100 the facilities, which span 110,000 square metres, the cumulative annual manufacturing capacity exceeds 2.5 billion tablets and capsules, as well as 120 million IVs and injectables, all enabling the production and global distribution of more than 10,000 Bio's portfolio focuses on key therapy areas that address some of the world's most pressing health needs, and support the full continuum of care - from prevention and diagnosis to treatment, ongoing support, and complementary forging long-term strategic partnerships with global industry leaders and top-tier academic institutions, Mubadala Bio is accelerating biopharma innovation and local manufacturing, cultivating world-class talent and driving accelerated advancements. This holistic strategy spans the full continuum of care by providing integrated disease solutions across prevention, diagnostics, treatment, supportive treatment, and complementary Bakheet Al Katheeri, Chief Executive Officer of Mubadala's UAE Investments Platform, said, "By launching Mubadala Bio, we are taking a transformative step towards strengthening national drug security and fostering innovation in life sciences. This positions Mubadala at the forefront of the industry, enabling us to drive long-term economic growth, build a resilient life sciences ecosystem, and elevate Abu Dhabi's role in delivering impactful health solutions on a global scale.""Through our National Champions, we continue our efforts to accelerate the UAE's economic diversification by investing in priority sectors and support building a knowledge-based economy," Al Katheeri Ali Abdulla, Executive Director of UAE Clusters at Mubadala's UAE Investments Platform, stated that the launch of Mubadala Bio marks a major milestone in the UAE's journey toward global leadership in the life sciences indsutry. He noted that the strategic focus will strengthen local capabilities in development, manufacturing, logistics, and distribution across the supply chain. Focusing on integrated biopharma and pharma logistics, Mubadala Bio aims to support the UAE's Centennial 2071 vision. As part of its launch, it will mark its first physical presence at the Make it in the Emirates 2025, showcasing the UAE's success in building a competitive life sciences industry, and reinforcing its position as a hub for innovation and local manufacturing.
Khaleej Times
24-04-2025
- Business
- Khaleej Times
Badr Jafar named UAE special envoy for business and philanthropy
In a move to boost global cooperation and sustainable development, the UAE has appointed Badr Jafar as Special Envoy for Business and Philanthropy. The announcement was made by Sheikh Abdullah bin Zayed Al Nahyan, Deputy Prime Minister and Minister of Foreign Affairs, as part of the country's broader efforts to strengthen ties between government, business and philanthropy. Jafar's new role aims to enhance the UAE's engagement with global business and philanthropic communities, reinforcing its commitment to innovation, investment and social progress. Speaking on his appointment, Jafar said he is deeply honoured and emphasized the need for bold, collective action to tackle global challenges. This appointment aligns with the UAE's strategic visions, including 'We the UAE 2031' and 'Centennial 2071', as the country continues to position itself as a global hub for sustainable finance and economic diplomacy. The UAE's non-oil sectors grew by 4.5 per cent in the first nine months of 2024, accounting for nearly 75 per cent of the nation's real GDP — a reflection of its thriving private sector and diversified economy. And with a top-10 global ranking in the World Giving Index in 2024, the UAE continues to demonstrate leadership in both economic and philanthropic impact. Strategic objectives of the Special Envoy: • CONNECTING: Facilitating engagement and coordination between the private sector and government entities in the UAE, and with the private sector internationally. • MOBILISING: Enabling business and philanthropy stakeholders to support the UAE's diplomatic and strategic objectives. • ADVOCATING: Promoting common understanding of the importance of public, private and philanthropic coordination and collaboration and the opportunities that exist to put it into practice.
Arabian Business
22-04-2025
- Business
- Arabian Business
UAE appoints Badr Jafar as Special Envoy for Business and Philanthropy
The United Arab Emirates has appointed Badr Jafar as Special Envoy for Business and Philanthropy, a move aimed at deepening ties between government, business and charitable sectors as the Gulf country seeks to bolster its role in sustainable development and economic diplomacy. The appointment was announced by Sheikh Abdullah bin Zayed Al Nahyan, the UAE's Minister of Foreign Affairs and Deputy Prime Minister, and comes as part of the country's broader strategy to enhance cooperation between the public and private sectors. Jafar, a prominent Emirati businessman and social entrepreneur, will be tasked with connecting domestic and international private sector actors with government institutions, mobilising support for the UAE's diplomatic initiatives, and advocating for greater coordination across business and philanthropy. The move aligns with the UAE's long-term development visions, including the 'We the UAE 2031' agenda and the 'Centennial 2071' plan, which aim to diversify the economy, position the country as a global hub for innovation and finance, and enhance its international influence. Non-oil sectors contributed approximately 75 per cent of the UAE's real GDP in the first nine months of 2024, growing by 4.5 per cent year-on-year – a sign of the expanding role of the private sector in the country's economic landscape. The UAE also ranked among the top 10 countries in the 2024 World Giving Index, underlining its increasing emphasis on philanthropy and social impact on the global stage.
